Search

Your search keyword '"Pharoah, P"' showing total 631 results

Search Constraints

Start Over You searched for: Author "Pharoah, P" Remove constraint Author: "Pharoah, P" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
631 results on '"Pharoah, P"'

Search Results

2. Germline copy number variants and endometrial cancer risk

3. Understanding the genetic complexity of puberty timing across the allele frequency spectrum

4. Improving on polygenic scores across complex traits using select and shrink with summary statistics (S4) and LDpred2

6. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

7. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

10. Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

11. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

12. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

13. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy

14. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

15. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

16. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

17. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

19. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

21. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

22. Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort studyResearch in context

23. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

24. Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

25. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

26. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

27. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

28. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

29. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

30. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

31. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

32. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

33. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

35. 2 Pathways to detection of non-infectious childhood uveitis in the UK: findings from the UNICORN cohort study

36. Evaluation and comparison of different breast cancer prognosis scores based on gene expression data

37. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis

38. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

40. Relevance of the MHC region for breast cancer susceptibility in Asians

41. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

42. Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action

43. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

44. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

45. Rare germline copy number variants (CNVs) and breast cancer risk

46. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

47. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

48. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

49. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

50. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

Catalog

Books, media, physical & digital resources